Advanced Dry Eye Treatment
Device for Eye Care Professionals

2-Minute Dry Eye Treatment. No Single-Use
Consumables. Built for Clinical Efficiency.

Replace time-intensive dry eye management with a fast, repeatable, in-office dry eye treatment designed for consistent clinical delivery.

Tixel-i is an FDA-cleared dry eye device for evaporative dry eye due to meibomian gland dysfunction. This non-laser dry eye treatment machine delivers a controlled procedure in approximately two minutes for both eyes, without adding complexity to your workflow.

Standardize care, reduce chair time, and introduce a scalable Tixel-i dry eye treatment that supports both patient outcomes and practice performance.

Treats upper and lower eyelids within the same protocol

No manual gland expression required

Safe for all skin types

hero-clinician

Why Clinics Are Replacing Traditional Dry Eye Treatment Models

Most dry eye treatment approaches limit efficiency and consistency.

  • Dependence on patient compliance
  • Recurring consumable costs
  • Long chair time per patient
  • Variable clinical outcomes

Tixel-i dry eye treatment introduces a structured, in-office procedure.

  • Clinician-controlled delivery
  • Standardized protocol across patients and staff
  • No single-use consumables
  • Repeatable outcomes across treatment cycles

This is a protocol-driven dry eye treatment machine designed to improve clinical consistency and operational performance.

Non-Laser Dry Eye Device With Controlled Energy Delivery

Remove Variability. Deliver Consistency.

Most systems rely on light-based energy with variable absorption and complex settings

Tixel-i uses Thermo-Mechanical Action (TMA), not light-based energy.

  • Non-laser dry eye device using controlled thermal pulses
  • Precise controlled thermal pulse delivery
  • No sinNo light absorption variabilitygle-use consumables
  • Repeatable oNo wavelength or parameter adjustmentstcomes across treatment cycles

Energy is delivered through a proprietary titanium tip designed for controlled, fractional treatment and simplified hygiene.

No contact with the eyeball

Safe periocular application

Consistent, controlled delivery

Explore Technology

Built for Clinical Workflow and Delegation

Increase Patient Throughput Without Extending Appointments

Tixel-i integrates directly into your clinic without disruption.

  • ~2-minute procedure for both eyes~40 pulses delivered per treatment (both eyes)
  • Preset protocol supports staff delegation
  • Minimal setup between patients
  • No infrastructure changes required
  • No consumables or inventory management

Treatment is delivered through a structured protocol of three sessions spaced two weeks apart, supporting consistent implementation across patients. This dry eye treatment machine allows your team to deliver more treatments within the same schedule, without increasing chair time.

Designed for Measurable, Sustained Improvement

Consistent Clinical Outcomes With Structured Treatment Protocols

Tixel-i delivers controlled thermal energy to the eyelid, supporting key functions behind evaporative dry eye.

  • Supports meibomian gland activity
  • Improves tear film stability
  • Reduces dry eye symptoms

Clinical outcomes show both subjective and objective improvement, with results sustained for months following treatment cycles.¹² Patients often report immediate effects, with continued improvement after treatment sessions.³ This makes Tixel-i dry eye treatment suitable for structured, long-term dry eye management.

View Clinical Results

Turn Dry Eye Into a Scalable Clinical Service

Increase Revenue Without Increasing Operational Complexity

Tixel-i adds a structured, procedure-based dry eye treatment to your practice.

  • Increase revenue per patient through repeatable treatment protocols
  • Retain dry eye patients within your clinic
  • Eliminate single-use consumable costs
  • Improve staff efficiency through delegation
  • Standardize treatment delivery across providers

With no consumables and a fast procedure time, this dry eye device supports a predictable and scalable service model.

Built for Every Eye Care Practice

Optometrists

Build a consistent, in-office dry eye treatment pathway and reduce external referrals.

See How It Works

Ophthalmologists

Integrate a protocol-driven Tixel-i dry eye treatment into ocular surface disease management.

See How It Works

LASIK Surgeons

Maintain a well-hydrated ocular surface before and after procedures to support visual accuracy and patient comfort.

See How It Works

Fast Implementation With No Operational Disruption

Go From Setup to Treatment Without Delays

Tixel-i is designed for rapid integration into clinical practice.

  • Standard treatment room setup
  • No additional equipment required
  • Training provided for safe, consistent delivery
  • Defined protocols for quick onboarding
  • No consumables or supply chain management

Your team can begin delivering dry eye treatment quickly, without disrupting daily operations.

Bring FDA-Cleared Tixel Dry Eye Treatment Into Your Practice

Dry eye is already part of your daily patient flow. Many current approaches depend on time, consumables, or patient compliance, which limits consistency.

Tixel-i introduces a structured, in-office dry eye treatment machine designed for evaporative dry eye due to MGD, with workflow built for efficiency, delegation, and repeatability.

Deliver a consistent Tixel dry eye treatment that supports clinical outcomes while improving operational performance.